[go: up one dir, main page]

Ødegård et al., 1978 - Google Patents

On use of chromogenic substrates for studies of coagulation inhibitors

Ødegård et al., 1978

Document ID
16426454537337417809
Author
Ødegård O
Lie M
Publication year
Publication venue
Pathophysiology of Haemostasis and Thrombosis

External Links

Snippet

Methodological problems encountered using chromogenic substrates on thrombin and Xa are discussed:(1) influence of substrate on inhibitor;(2) influence of heparin;(3) optimal concentrations;(4) specificity;(5) denatured enzymes, and (6) natural versus chromogenic …
Continue reading at karger.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof

Similar Documents

Publication Publication Date Title
Eitzman et al. Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.
Conard et al. Molar antithrombin concentration in normal human plasma
Collen On the regulation and control of fibrinolysis
Kluft et al. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin
Abildgaard et al. Comparison of progressive antithrombin activity and the concentrations of three thrombin inhibitors in human plasma
Blombäck et al. The assay of antithrombin using a synthetic chromogenic substrate for thrombin
Aoki et al. Congenital deficiency of α 2-plasmin inhibitor associated with severe hemorrhagic tendency
Ødegård et al. Heparin cofactor activity measured with an amidolytic method
Teger-Nilsson et al. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate
Abildgaard Inhibition of the thrombin‐fibrinogen reaction by heparin and purified cofactor
Aoki Natural inhibitors of fibrinolysis
Fuchs et al. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
ECKLE et al. Protein C degradation in vitro by neutrophil elastase
Seegers Antithrombin III. Theory and Clinical Applications: HP Smith Memorial Lecture
Glas-Greenwalt et al. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus
US4496653A (en) Process for the determination of antithrombin-BM
IE902431A1 (en) Assaying of plasma proteins
Hedner et al. Inhibition of activated haceman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor)
Pabinger-Fasching et al. High levels of plasma protein C in nephrotic syndrome
Spannagl et al. A purified antithrombin III-heparin complex as a potent inhibitor of thrombin in porcine endotoxin shock
Ødegård et al. On use of chromogenic substrates for studies of coagulation inhibitors
Blombäck et al. Action of a proteolytic enzyme inhibitor on blood coagulation in vitro
Khan et al. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass
Blombäck et al. Studies on thrombin inactivation in normal plasma, serum and plasma fractions, and its relation to heparin
EP0576038B1 (en) Method for measuring tissue plasminogen activator, antithrombin III and soluble fibrin